Gennex Laboratories Limited (BOM:531739)
India
· Delayed Price · Currency is INR 12.07
-0.50 (-3.98%)
At close: May 9, 2025
Gennex Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | 131.75 | 49.21 | 39.23 | 40.38 | 18.56 | Upgrade
|
| Depreciation & Amortization | 23.68 | 9.19 | 7.88 | 8.81 | 10.05 | Upgrade
|
| Other Operating Activities | 25.98 | 1.45 | 20.2 | 1.8 | 13.63 | Upgrade
|
| Change in Accounts Receivable | -83.95 | 18.97 | -23.67 | -26.67 | 41.18 | Upgrade
|
| Change in Inventory | -94.83 | -79.56 | -27.18 | 24.19 | -21.1 | Upgrade
|
| Change in Accounts Payable | 20.5 | 124.46 | 54.74 | -39.32 | 22.62 | Upgrade
|
| Change in Other Net Operating Assets | -490 | 113.04 | 47.88 | -23.56 | -101.65 | Upgrade
|
| Operating Cash Flow | -466.86 | 236.76 | 119.08 | -14.37 | -16.71 | Upgrade
|
| Operating Cash Flow Growth | - | 98.82% | - | - | - | Upgrade
|
| Capital Expenditures | - | -397.86 | -15.94 | -0.79 | -2.95 | Upgrade
|
| Sale of Property, Plant & Equipment | 153.53 | 0.5 | 0.29 | - | - | Upgrade
|
| Investment in Securities | - | -12.54 | - | - | - | Upgrade
|
| Other Investing Activities | 35.6 | 26.61 | -9 | 0.54 | 0.79 | Upgrade
|
| Investing Cash Flow | 189.13 | -383.29 | -24.66 | -0.25 | -2.15 | Upgrade
|
| Short-Term Debt Issued | - | - | 27.62 | 23.78 | 4.46 | Upgrade
|
| Long-Term Debt Issued | - | 10.18 | - | - | - | Upgrade
|
| Total Debt Issued | - | 10.18 | 27.62 | 23.78 | 4.46 | Upgrade
|
| Short-Term Debt Repaid | - | -90.7 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -30.72 | - | -37.15 | -0.15 | -0.39 | Upgrade
|
| Total Debt Repaid | -30.72 | -90.7 | -37.15 | -0.15 | -0.39 | Upgrade
|
| Net Debt Issued (Repaid) | -30.72 | -80.52 | -9.54 | 23.62 | 4.06 | Upgrade
|
| Issuance of Common Stock | 798.32 | 304.39 | - | - | - | Upgrade
|
| Other Financing Activities | -30.76 | -13.54 | -8.77 | -7.44 | -7.54 | Upgrade
|
| Financing Cash Flow | 736.84 | 210.33 | -18.31 | 16.19 | -3.47 | Upgrade
|
| Net Cash Flow | 459.11 | 63.81 | 76.11 | 1.57 | -22.34 | Upgrade
|
| Free Cash Flow | -466.86 | -161.1 | 103.14 | -15.16 | -19.66 | Upgrade
|
| Free Cash Flow Margin | -53.84% | -24.56% | 16.85% | -2.54% | -3.50% | Upgrade
|
| Free Cash Flow Per Share | -2.15 | -1.04 | 0.81 | -0.12 | -0.15 | Upgrade
|
| Cash Interest Paid | 30.76 | 13.54 | 8.77 | 7.44 | 7.54 | Upgrade
|
| Cash Income Tax Paid | - | - | 11.1 | 15.34 | 0.04 | Upgrade
|
| Levered Free Cash Flow | -511.57 | -175.84 | 17.82 | -30 | -7.37 | Upgrade
|
| Unlevered Free Cash Flow | -492.34 | -167.38 | 23.3 | -25.35 | -2.66 | Upgrade
|
| Change in Net Working Capital | 609.89 | -195.96 | -2.06 | 69.49 | 27.94 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.